Refractory Bullous Pemphigoid Successfully Treated with Reslizumab: A Possible Novel Therapeutic Modality.
Ann Dermatol
; 35(Suppl 1): S103-S106, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-37853878
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ann Dermatol
Year:
2023
Document type:
Article
Country of publication: